Interestingly, FGFR1 phosphorylation was increased in the tumor tissues after TAE684 treatment, suggesting that the FGFR pathway might compensate for inhibition of ALK signaling (Figure 2A–C). This evidence concerns the gene FGFR1 and neoplasm.